AMERICAN GENE ENGINEER CORP - FORM 10-K - EX-32.2 - EXHIBIT 32.2 - February 12, 2015

Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - AMERICAN GENE ENGINEER CORPFinancial_Report.xls
EX-31.2 - EXHIBIT 31.2 - AMERICAN GENE ENGINEER CORPex31_2.htm
EX-31.1 - EXHIBIT 31.1 - AMERICAN GENE ENGINEER CORPex31_1.htm
EX-21.1 - EXHIBIT 21.1 - AMERICAN GENE ENGINEER CORPex21_1.htm
EX-32.1 - EXHIBIT 32.1 - AMERICAN GENE ENGINEER CORPex32_1.htm
10-K - FOR THE FISCAL YEAR ENDED OCTOBER 31, 2014 - AMERICAN GENE ENGINEER CORPm21015010k.htm
Exhibit 32.2

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
 
In connection with the Annual Report of American Gene Engineer Corp. (the “Company”) on Form 10-K for the year ended October 31, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Han-Chen Lin, Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. section 1350 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
 
(1)
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
         
       
Dated: February 12, 2015
      
By:
  
/s/ Han-Chen Lin
           
Han-Chen Lin
Chief Financial Officer
(Principal Financial Officer and
Principal Accounting Officer)  
 
 
 

AMERICAN GENE ENGINEER CORP Reports